Magic mushroom study: does the 'Trip' cause the benefits?
NCT ID NCT06768944
First seen Jan 08, 2026 · Last updated May 27, 2026 · Updated 20 times
Summary
This study looks at whether the intense, mind-altering experience caused by psilocybin (the active ingredient in magic mushrooms) is necessary for its positive after-effects. Healthy volunteers will receive psilocybin along with either a placebo or risperidone, a drug that blocks the psychedelic effects. Researchers will then compare changes in mood, stress, and outlook to see if blocking the experience also blocks the benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVESTIGATING THE IMPORTANCE OF THE SUBJECTIVE PSYCHEDELIC EXPERIENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Calgary
RECRUITINGCalgary, Alberta, T2N 4N1, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.